These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 17130580)
41. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides. Reddy S; Cheung CC; Chai RC; Rodrigues JA Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289 [TBL] [Abstract][Full Text] [Related]
42. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes. Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924 [TBL] [Abstract][Full Text] [Related]
43. Insulin as a T cell antigen in type 1 diabetes supported by the evidence from the insulin knockout NOD mice. Moriyama H; Nagata M; Arai T; Okumachi Y; Yamada K; Kotani R; Yasuda H; Hara K; Yokono K Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S155-60. PubMed ID: 17459508 [TBL] [Abstract][Full Text] [Related]
44. Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice. Mor A; Kloog Y; Keren G; George J Eur J Pharmacol; 2009 Aug; 616(1-3):301-5. PubMed ID: 19527709 [TBL] [Abstract][Full Text] [Related]
45. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus. Teranishi T; Ohara T; Maeda K; Zenibayashi M; Kouyama K; Hirota Y; Kawamitsu H; Fujii M; Sugimura K; Kasuga M Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455 [TBL] [Abstract][Full Text] [Related]
46. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973 [TBL] [Abstract][Full Text] [Related]
47. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice. Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870 [TBL] [Abstract][Full Text] [Related]
48. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice. Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228 [TBL] [Abstract][Full Text] [Related]
49. The new clinical trials with thiazolidinediones--DREAM, ADOPT, and CHICAGO: promises fulfilled? Goldberg RB Curr Opin Lipidol; 2007 Aug; 18(4):435-42. PubMed ID: 17620861 [TBL] [Abstract][Full Text] [Related]
50. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications. Krentz A Diabetes Metab Res Rev; 2009 Feb; 25(2):112-26. PubMed ID: 19219860 [TBL] [Abstract][Full Text] [Related]
51. Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice. Schmid S; Koczwara K; Schwinghammer S; Lampasona V; Ziegler AG; Bonifacio E Clin Immunol; 2004 Apr; 111(1):108-18. PubMed ID: 15093559 [TBL] [Abstract][Full Text] [Related]
52. Bone marrow is a preferential homing site for autoreactive T-cells in type 1 diabetes. Li R; Perez N; Karumuthil-Melethil S; Vasu C Diabetes; 2007 Sep; 56(9):2251-9. PubMed ID: 17596402 [TBL] [Abstract][Full Text] [Related]
53. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity. Ghanaat-Pour H; Sjöholm A Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603 [TBL] [Abstract][Full Text] [Related]
54. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice. Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422 [TBL] [Abstract][Full Text] [Related]
55. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone. Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393 [TBL] [Abstract][Full Text] [Related]
56. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Beales PE; Pozzilli P Diabetes Metab Res Rev; 2002; 18(2):114-7. PubMed ID: 11994902 [TBL] [Abstract][Full Text] [Related]
57. Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A. Casteels K; Waer M; Bouillon R; Allewaert K; Laureys J; Mathieu C Transplant Proc; 1996 Dec; 28(6):3095. PubMed ID: 8962198 [No Abstract] [Full Text] [Related]
58. Controversies on the prevention of insulin-dependent diabetes mellitus by immunomodulation: lessons from NOD mice treated with beta-1,6;1,3-D-glucan and rhIGF-I. Kida K; Kaino Y; Ito T; Hirai H J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():327-33. PubMed ID: 9642663 [No Abstract] [Full Text] [Related]
59. Protective role for plasmid DNA-mediated VIP gene transfer in non-obese diabetic mice. Herrera JL; Fernández-Montesinos R; González-Rey E; Delgado M; Pozo D Ann N Y Acad Sci; 2006 Jul; 1070():337-41. PubMed ID: 16888188 [TBL] [Abstract][Full Text] [Related]
60. Sequential conversion of the redox status of macrophages dictates the pathological progression of autoimmune diabetes. Murata Y; Amao M; Hamuro J Eur J Immunol; 2003 Apr; 33(4):1001-11. PubMed ID: 12672066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]